Ara
Toplam kayıt 77, listelenen: 31-40
Autonomic imbalance in sepsis
(W B Saunders Co-Elsevier Inc, 2018)
Comparison of the Effects of Levosimendan Dobutamine and Vasodilator Therapy on Ongoing Myocardial Injury in Acute Decompensated Heart Failure
(Sage Publications Inc, 2017)
Background: Cardiac troponins (cTn) are reliable and the most sensitive biomarker in the setting of acute decompensated heart failure (ADHF). Acute decompensated heart failure is usually associated with worsening chronic ...
Coronary artery disease in outpatients with nonvalvular atrial fibrillation: results from the multicenter RAMSES study
(Lippincott Williams & Wilkins, 2016)
Background Nonvalvular atrial fibrillation (NVAF) frequently coexists with coronary artery disease (CAD). However, the optimal antithrombotic strategy for patients with concomitant CAD and NVAF is controversial. The aim ...
Prediction of atrial fibrillation risk in the community
(Elsevier Ireland Ltd, 2016)
Letter to editor
Allergic myocardial infarction: Type I Kounis syndrome following blue crab consumption
(Taylor & Francis Ltd, 2019)
Objectives: Allergic myocardial infarction, known as Kounis syndrome, is an acute myocardial infarction after an allergic reaction to food, drugs, or insect stings, etc. Kounis syndrome can also be caused by all kinds of ...
ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study)
(Turkish Soc Cardiology, 2016)
Objective: Data regarding stroke prevention strategies in non-valvular atrial fibrillation (NVAF) are limited to vitamin K antagonists (VKAs). This study aimed to evaluate real-life stroke prevention strategies for NVAF ...
Suboptimal use of non-vitamin K antagonist oral anticoagulants: Results from the RAMSES study
(Lippincott Williams & Wilkins, 2016)
This study aimed to investigate the potential misuse of novel oral anticoagulants (NOACs) and the physicians' adherence to current European guideline recommendations in real-world using a large dataset from Real-life ...
Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study
(Springer, 2017)
The definition of non-valvular atrial fibrillation (NVAF) is controversial. We aimed to assess the impact of valvular heart disease on stroke prevention strategies in NVAF patients. The RAMSES study was a multicenter and ...
Guideline-adherent therapy for stroke prevention in atrial fibrillation in different health care settings: Results from RAMSES study
(Elsevier Science Bv, 2017)
Objective: No studies have been conducted in Turkey to compare the quality of stroke prevention therapies provided in different healthcare settings in patients with atrial fibrillation (AF). Therefore, we aimed to evaluate ...
Real-World Clinical Characteristics and Treatment Patterns of Individuals Aged 80 and Older with Nonvalvular Atrial Fibrillation: Results from the ReAl-life Multicenter Survey Evaluating Stroke Study
(Wiley, 2017)
ObjectivesTo compare the clinical characteristics of and use of oral anticoagulant (OAC) therapy in individuals aged 80 and older with atrial fibrillation (AF) with those of individuals younger than 80 with AF in clinical ...
